Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

The MassDevice Big 100 The MassDevice Big 100 details the world's 100 largest medical device players, ranked by 2010 revenues. The book features: Company
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Congressional panel wants priority review program for medtech

January 27, 2015 by Brian Johnson

21st Century Cures, a bipartisan panel led by Reps. Fred Upton (R-Mich.) and Diana DeGette (D-Colo.), calls for the FDA to create a new, expedited review process for medical technology designed to address unmet needs.

Congressional panel wants priority review program for medtech

A congressional panel is calling fora new, expedited priority review process for medical technology aimed at unmet medical needs, similar to similar programs for drugs and biologics.

FDA approves St. Jude Medical's FlexAbility catheter

January 27, 2015 by Brad Perriello

The FDA approves St. Jude Medical's FlexAbility ablation catheter for treating cardiac fibrillation.

FDA approves St. Jude Medical's FlexAbility catheter

Stryker's Q4, 2014 profits slump on recall costs

January 27, 2015 by Brad Perriello

Stryker reports slumping profits for the 4th quarter and all of 2014, blaming in part the recalls of its Rejuvenate and ABG II hip implants and Neptune waste management device.

Stryker's Q4, 2014 profits slump on recall costs

Stryker (NYSE:SYK) today reported slumping profits for the 4th quarter and all of 2014, missing earnings expectations by a penny after the cost of several recalls suppressed the bottom line.

FDA approves Abiomed's Impella RP

January 27, 2015 by Brad Perriello

Abiomed wins a humanitarian device exemption for its Impella RP

FDA approves Abiomed's Impella RP

Abiomed (NSDQ:ABMD) today said the FDA approved a humanitarian device exemption for its Impella RP heart pump, calling the device the 1st FDA-approved percutaneous, single-access pump for supporting the heart's right ventricle.

MassDevice.com +3 | The top 3 medtech stories for January 27, 2015

January 27, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Philips' Q4 profits plunge on Cleveland plant closing

January 27, 2015 by Brad Perriello

The closure of a Cleveland plant that makes CT scanners pushed Royal Philips' overall profits down and slashed its Philips Healthcare division's bottom line by nearly 28%.

Philips' Q4 profits plunge on Cleveland plant closing

MDT wins HDE for Enterra II | Regulatory news for the week of January 26, 2015

January 27, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Medtronic wins HDE for Enterra II neurostim device; FDA officially clears Integra's Puerto Rico plant; Nevro surges on Senza approvable letter from FDA; mHealth: AliveCor wins CE Mark for new afib algorithm; FDA warns against pediatric use of bone growth proteins

Medtronic wins HDE for Enterra II neurostim device

January 23, 2015 by Brad Perriello

With Q1 healthcare profits down 13%, Siemens shakes up management

January 27, 2015 by Brad Perriello

With fiscal 1st-quarter profits down nearly 13% at Siemens Healthcare, the German conglomerate shakes things up with a new management team.

With Q1 healthcare profits down 13%, Siemens shakes up management